Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Ticagrelor With Morphine +/- Naloxone in Unstable Angina
NCT02939248Phase 4Completed
- Sponsor
- Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz
- Start
- Oct 2016
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of naloxone in unstable angina pectoris (UA) (2 arms), sponsored by Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz. Primary endpoint: Time to Maximum Plasma Concentration at 6 hours. Started Oct 2016; status: completed.
02
Drugs
naloxone
03
Conditions
unstable angina pectoris (UA)
Beyond the preview
Go deeper on NCT02939248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02939248.